IgE-mediated anaphylactic reaction to purified and recombinant factor VIII in a patient with severe haemophilia A

被引:16
|
作者
Kadar, J. G.
Schuster, J.
Hunzelmann, N.
机构
[1] Klin & Poliklin Dermatol & Vererol, D-50931 Cologne, Germany
[2] Univ Cologne, Outpatient Clin, Cologne, Germany
[3] Univ Cologne, Lab Transfus Med, Cologne, Germany
[4] Univ Cologne, Dept Dermatol, Cologne, Germany
关键词
allergy; bleeding disorder; IgE-mediated reaction; inhibitors; recombinant;
D O I
10.1111/j.1365-2516.2006.01339.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report a 51-year-old patient with severe haemophilia A developing a severe life-threatening anaphylactic reaction to recombinant factor VIII (rFVIII). Anaphylactic reactions are a rare but well-known side effect of FVIII products. The nature of these reactions could not be clarified as previous studies failed to demonstrate a specific IgE response. Here, we could prove a grade 3 anaphlyactic reaction as an IgE-mediated response to rFVIII for the first time by Western blotting.
引用
收藏
页码:104 / 105
页数:2
相关论文
共 50 条
  • [41] Emodin, a naturally occurring anthraquinone derivative, suppresses IgE-mediated anaphylactic reaction and mast cell activation
    Lu, Yue
    Yang, Ju Hye
    Li, Xian
    Hwangbo, Kyoung
    Hwang, Seung-Lark
    Taketomi, Yoshitaka
    Murakami, Makoto
    Chang, Young-Chae
    Kim, Cheorl-Ho
    Son, Jong-Keun
    Chang, Hyeun Wook
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (11) : 1700 - 1708
  • [42] IgE-mediated anaphylactic reactions to neuromuscular blocking agents: Can they be prevented?
    E. Florvaag
    S. G. O. Johansson
    Current Allergy and Asthma Reports, 2008, 8 : 375 - 376
  • [43] IgE-mediated anaphylactic reactions to neuromuscular blocking agents: Can they be prevented?
    Florvaag, E.
    Johansson, S. G. O.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2008, 8 (05) : 375 - 376
  • [44] Allergic reaction mediated by IgE in hemophilia A patient using plasma-derived factor VIII concentrate is not acting against factor VIII protein
    Montalvao, Silmara
    Tucunduva, Aline
    Sambo, Andrea
    Medina, Samuel
    Ozelo, Margareth
    HAEMOPHILIA, 2014, 20 : 51 - 51
  • [45] IgE-mediated allergy to recombinant human insulin in a diabetic
    Baur, X
    Bossert, J
    Koops, F
    ALLERGY, 2003, 58 (07) : 676 - 678
  • [46] Role of selectins on IgE-mediated skin reaction
    Wada, Y
    Kuzuhara, A
    Hanamura, M
    Kida, R
    Yoshinaka, T
    Saito, T
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (08) : 1531 - 1536
  • [47] POSSIBLE ROLE OF IGE-MEDIATED REACTION IN IMMUNITY
    STEINBERG, P
    ISHIZAKA, K
    NORMAN, PS
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1974, 54 (06) : 359 - 366
  • [48] Dieckol, a phlorotannin of Ecklonia cava, suppresses IgE-mediated mast cell activation and passive cutaneous anaphylactic reaction
    Ahn, Ginnae
    Amagai, Yosuke
    Matsuda, Akira
    Kang, Sung-Myung
    Lee, WonWoo
    Jung, Kyungsook
    Oida, Kumiko
    Jang, Hyosun
    Ishizaka, Saori
    Matsuda, Kenshiro
    Jeon, You-Jin
    Jee, Youngheun
    Matsuda, Hiroshi
    Tanaka, Akane
    EXPERIMENTAL DERMATOLOGY, 2015, 24 (12) : 968 - 970
  • [49] PERIOPERATIVE MANAGEMENT OF PATIENTS WITH SEVERE HAEMOPHILIA A WITH RECOMBINANT FACTOR VIII FC FUSION PROTEIN (RFVIIIFC)
    Bocchinfuso, S.
    O'Donovan, M.
    Singleton, E.
    Benson, J.
    Byrne, M.
    Ryan, K.
    O'Donnell, J. S.
    O'Connell, N. M.
    HAEMOPHILIA, 2021, 27 : 105 - 106
  • [50] Severe anaphylactic reaction to glatiramer acetate with specific IgE
    Rauschka, H
    Farina, C
    Sator, P
    Gudek, S
    Breier, F
    Schmidbauer, M
    NEUROLOGY, 2005, 64 (08) : 1481 - 1482